JPS59176211A - 緑内障治療用薬理学的調剤 - Google Patents

緑内障治療用薬理学的調剤

Info

Publication number
JPS59176211A
JPS59176211A JP59001434A JP143484A JPS59176211A JP S59176211 A JPS59176211 A JP S59176211A JP 59001434 A JP59001434 A JP 59001434A JP 143484 A JP143484 A JP 143484A JP S59176211 A JPS59176211 A JP S59176211A
Authority
JP
Japan
Prior art keywords
carazolol
glaucoma
solution
acid
intraocular pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59001434A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0521890B2 (2
Inventor
ヴオルフガング・バルチユ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of JPS59176211A publication Critical patent/JPS59176211A/ja
Publication of JPH0521890B2 publication Critical patent/JPH0521890B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP59001434A 1983-01-13 1984-01-10 緑内障治療用薬理学的調剤 Granted JPS59176211A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833300933 DE3300933A1 (de) 1983-01-13 1983-01-13 Verwendung von d,l- und d-carazolol als antiglaukommittel sowie arzneimittel, die diese stoffe enthalten
DE33009333 1983-01-13

Publications (2)

Publication Number Publication Date
JPS59176211A true JPS59176211A (ja) 1984-10-05
JPH0521890B2 JPH0521890B2 (2) 1993-03-25

Family

ID=6188200

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59001434A Granted JPS59176211A (ja) 1983-01-13 1984-01-10 緑内障治療用薬理学的調剤

Country Status (5)

Country Link
US (1) US4760085A (2)
EP (1) EP0114048B1 (2)
JP (1) JPS59176211A (2)
AT (1) ATE25195T1 (2)
DE (2) DE3300933A1 (2)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63313728A (ja) * 1987-04-03 1988-12-21 ザ・トラステイーズ・オブ・コロンビア・ユニヴアーシテイ・イン・ザ・シテイ・オブ・ニユー・ヨーク プロスタグランジンとアドレナリン性遮断剤との組合せからなる眼圧降下用組成物

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3319027A1 (de) * 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten
DE3540149A1 (de) * 1985-11-13 1987-05-14 Boehringer Mannheim Gmbh Verwendung von 1-(benztriazol-4-yloxy)3-(2-(2-methoxyphenoxy) -ethylamino)-2-propanol als antiglaukommittel, optisch aktive r und s isomere dieser substanz, verfahren zur herstellung derselben sowie arzneimittel, die diese substanzen enthalten
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
WO2000007584A2 (en) * 1998-08-04 2000-02-17 Wisconsin Alumni Research Foundation Method of reducing retinal ganglion cell degeneration
EP1802300A4 (en) * 2004-10-13 2009-05-27 Merck & Co Inc OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF EYE HIGH PRESSURE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
GB1369580A (en) * 1972-08-18 1974-10-09 Boehringer Mannheim Gmbh Tricyclic diphenylamine derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63313728A (ja) * 1987-04-03 1988-12-21 ザ・トラステイーズ・オブ・コロンビア・ユニヴアーシテイ・イン・ザ・シテイ・オブ・ニユー・ヨーク プロスタグランジンとアドレナリン性遮断剤との組合せからなる眼圧降下用組成物

Also Published As

Publication number Publication date
EP0114048B1 (de) 1987-01-28
JPH0521890B2 (2) 1993-03-25
EP0114048A3 (en) 1984-08-29
ATE25195T1 (de) 1987-02-15
DE3300933A1 (de) 1984-07-19
DE3462220D1 (en) 1987-03-05
EP0114048A2 (de) 1984-07-25
US4760085A (en) 1988-07-26

Similar Documents

Publication Publication Date Title
EP4245752A2 (en) Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
CS241484B2 (en) Method of 3- (4- )2-hydroxy-3-isopropyl-aminopropoxy (phenyl)alkane acids production
JPS62230722A (ja) 肥満および／または関連状態の治療剤
JPS63264556A (ja) 抗不整脈薬
JPS59176211A (ja) 緑内障治療用薬理学的調剤
CS202036B2 (en) Process for preparing new p-hydroxyphenoxypropanolamines
BG62066B2 (bg) (s)-(-)-1-пропил-2',6'-пипеколоксилидидов хидрохлорид монохидрат, метод за получаването му и фармацевтичен препарат, който го съдържа
CA1157778A (en) Nasal dosage forms of propranolol
TW416944B (en) Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
KR20010024747A (ko) 페닐아미노알킬카르복실산 유도체 및 그것을 함유하는의약조성물
KR20230158458A (ko) 리피테그라스트 결정형 및 이를 포함하는 약제학적 조성물
HU184859B (en) Process for producing new 1-figure bracket-square bracket-bracket-alkoxy-carbonyl-bracket closed-alkyl-square bracket closed-amino-figure bracket closed-3-bracket-substituted phenoxy-bracket closed-2-propanol derivatives
EP0024960A2 (fr) Nouvelles phénoxyamines hétérocycliques substituées, procédé pour leur préparation et leur application comme anesthésiques locaux
HU210683B (en) Process for producing n-benzyl-n1-(phenyl-alkyl)-thiourea derivatives and pharmaceutical compositions containing the same
CN110384698B (zh) 一种适用于彩超引导下对臂丛神经麻醉的麻醉剂及其应用
JPS5934695B2 (ja) 新規脱コレステロ−ル化合物の製法
JPH0633247B2 (ja) ３―アミノプロポキシフェニル誘導体およびその製法ならび用途
TWI465416B (zh) 胺甲酸酯立體異構物
JPH02258751A (ja) ３，４―ジヒドロキシベンゾイルオキシプロパノールアミン類のプロドラッグ
EP0710482B1 (en) Therapeutic agent for myocardial ischemic damages or reperfusion injuries
CS199571B2 (en) Method of preparing l-1-/4'-hydroxyphenoxy/-2-hydroxy-3-isopropyl aminopropane
JPS63218652A (ja) 新規グアニジノメチル安息香酸誘導体およびこれを含有する消化性潰瘍治療剤
PL96042B1 (pl) Sposob wytwarzania nowych aminopochodnych azydofenoli
JP7418502B2 (ja) 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用
FI76319C (fi) Foerfarande foer framstaellning av nya substituerade 3-fenoxi-1-alkoxikarbonyl-alkylamino-propanol-2 -foereningar med -receptor haemmande verkan.